StonvexLoading…
StonvexStonvexStonvexCore line items from BGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 | Annual 2021 2021-09-30 |
|---|---|---|---|---|
Revenue | $25.10M | $46.47M | $64.86M | $57.10M |
Operating Income | $-563.77K | $-2.61M | $2.10M | $2.39M |
Net Income | $-1.44M | $-7.78M | $1.08M | $3.15M |
EPS (Diluted) | $-0.20 | $-1.08 | $0.15 | $0.09 |
Total Assets | $53.00M | $51.26M | $64.53M | $75.35M |
Total Liabilities | $8.91M | $6.91M | $9.56M | $18.68M |
Cash & Equivalents | $9.82M | $7.48M | $14.32M | $10.47M |
Free Cash Flow OCF − CapEx | $304.11K | $132.45K | $10.62M | $-1.15M |
Shares Outstanding | 7.23M | 7.23M | 7.23M | 35.75M |